To identify compounds that inhibit SREBP activity, we used a human hepatoma Huh-7 cell line that stably expressed a luciferase reporter gene under the control of an SREBP-driven FAS promoter (Huh-7/FAS-luc). The gene discussed is FAS; the disease is hepatocellular carcinoma.